OBN: Supporting Emerging Life Sciences Companies

OBN is the Membership organisation supporting and bringing together the UK’s emerging life sciences companies, corporate partners and investors. Our 360-plus Member companies are located across the Golden Triangle and beyond to Nottingham, Manchester and Scotland benefiting from our networking, partnering, purchasing, advising and advocacy activities.

OBN_ID_RGB

OBN Senior Executive Club – Lunch: Corporate Venture & Emerging Companies Summit, Cambridge (Invitation-only)

Thursday 5 February 2015

In response to demand from members in the East of England and London, OBN’s Senior Exec Club Cambridge will be held at lunchtime. OBN is inviting a number of Corporate Venture Capital firms, including some of those that have invested in our members’ organisations, to make presentations and network with members.

According to published reports, CVC investees garner a higher percentage of licensing deals and collaborations, achieve more M&A and more IPOs. In the past decade CVCs participated in ~10% of investment rounds in biotechs, but this now exceeds 20%. In some VC portfolios it exceeds 70%. The statistics suggest that CVCs pick investments well, their investees get pharma validation and active deal management, and the outcomes are better.

So join us for lunch; it could be the most valuable lunchtime networking event you’ve attended.

See you from 12:00 onwards!

Read more
OUR PATRONS & SPONSORS
OUR SUPPORTERS
LATEST NEWS
27
January
Oxford Immunotec to Present at the 2015 Leerink Global Healthcare Conference
Tuesday, January 27th, 2015
27 January 27 2015: Oxford, UK & Marlborough, USA  – Oxford Immunotec Global PLC (Nasdaq: OX ... Read More »
26
January
Glide Appoints Albany Molecular Research for Manufacture of Novel Octreotide Solid Dose Formulation Clinical Trial Product
Monday, January 26th, 2015
26 January 2015: OXFORD, UK – Glide Technologies, the development company focused on solid dos ... Read More »
26
January
Shire’s Investigational SHP609, idursulfase-IT, Receives FDA Fast Track Designation for the Treatment of Neurocognitive Decline Associated with Hunter Syndrome
Monday, January 26th, 2015
26 January 2015: Basingstoke, UK &Lexington, USA – Shire plc announces that the United States ... Read More »
LATEST JOBS
23
January
Medicinal Chemist
Friday, January 23rd, 2015
Sygnature Discovery is an award winning provider of fully integrated drug discovery research program ... Read More »
23
January
Bioscientist
Friday, January 23rd, 2015
Sygnature Discovery is an award winning provider of fully integrated drug discovery research program ... Read More »
23
January
Senior DMPK Scientist
Friday, January 23rd, 2015
Sygnature Discovery is the UK’s largest independent provider of integrated drug discovery resource ... Read More »